HU900394D0 - Process for producing a new compound of medical effect and pharmaceutical preparatives containing it - Google Patents

Process for producing a new compound of medical effect and pharmaceutical preparatives containing it

Info

Publication number
HU900394D0
HU900394D0 HU90394A HU39489A HU900394D0 HU 900394 D0 HU900394 D0 HU 900394D0 HU 90394 A HU90394 A HU 90394A HU 39489 A HU39489 A HU 39489A HU 900394 D0 HU900394 D0 HU 900394D0
Authority
HU
Hungary
Prior art keywords
producing
new compound
medical effect
preparatives containing
pharmaceutical preparatives
Prior art date
Application number
HU90394A
Other languages
Hungarian (hu)
Other versions
HUT58310A (en
Inventor
Ronald Gammill
Thomas M Judge
Joel Morris
Original Assignee
Upjohn Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Upjohn Co filed Critical Upjohn Co
Publication of HU900394D0 publication Critical patent/HU900394D0/en
Publication of HUT58310A publication Critical patent/HUT58310A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D265/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
    • C07D265/04—1,3-Oxazines; Hydrogenated 1,3-oxazines
    • C07D265/12—1,3-Oxazines; Hydrogenated 1,3-oxazines condensed with carbocyclic rings or ring systems
    • C07D265/14—1,3-Oxazines; Hydrogenated 1,3-oxazines condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • C07D265/20—1,3-Oxazines; Hydrogenated 1,3-oxazines condensed with carbocyclic rings or ring systems condensed with one six-membered ring with hetero atoms directly attached in position 4
    • C07D265/22—Oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/22—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Cardiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Vascular Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Urology & Nephrology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
HU90394A 1988-12-21 1989-12-15 Anti-atherosclerotic and anti-thrombotic 1-benzopyran-4-one- and 2-amino-1,3-benzoxazin-4-one derivatives, process for producing them and pharmaceutical compositions containing them HUT58310A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US28779688A 1988-12-21 1988-12-21

Publications (2)

Publication Number Publication Date
HU900394D0 true HU900394D0 (en) 1991-09-30
HUT58310A HUT58310A (en) 1992-02-28

Family

ID=23104392

Family Applications (2)

Application Number Title Priority Date Filing Date
HU90394A HUT58310A (en) 1988-12-21 1989-12-15 Anti-atherosclerotic and anti-thrombotic 1-benzopyran-4-one- and 2-amino-1,3-benzoxazin-4-one derivatives, process for producing them and pharmaceutical compositions containing them
HU95P/P00411P HU211339A9 (en) 1988-12-21 1995-06-23 Antiatherosclerotic and antithrombotic 1-benzopyran-4-ones and 2-amino-1,3-benzoxazine-4-ones

Family Applications After (1)

Application Number Title Priority Date Filing Date
HU95P/P00411P HU211339A9 (en) 1988-12-21 1995-06-23 Antiatherosclerotic and antithrombotic 1-benzopyran-4-ones and 2-amino-1,3-benzoxazine-4-ones

Country Status (8)

Country Link
EP (1) EP0459983A1 (en)
JP (1) JPH04502322A (en)
AU (1) AU634994B2 (en)
DK (1) DK118791D0 (en)
FI (1) FI912995A0 (en)
HU (2) HUT58310A (en)
RU (1) RU2118321C1 (en)
WO (1) WO1990006921A1 (en)

Families Citing this family (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1991019707A2 (en) * 1990-06-20 1991-12-26 The Upjohn Company Antiatherosclerotic and antithrombotic 1-benzopyran-4-ones and 2-amino-1,3-benzoxazine-4-ones
US5302613A (en) * 1990-06-29 1994-04-12 The Upjohn Company Antiatheroscleroic and antithrombotic 2-amino-6-phenyl-4H-pyran-4-ones
JPH05501886A (en) * 1990-06-29 1993-04-08 ジ・アップジョン・カンパニー Antiatherosclerotic and antithrombotic 2-amino-6-phenyl-4H-pyran-4-ones
US5252735A (en) * 1990-06-29 1993-10-12 The Upjohn Company Antiatherosclerotic and antithrombotic 2-amino-6-phenyl-4H-pyran-4-ones
IL112764A0 (en) * 1994-03-18 1995-05-26 Ferrer Int New chromene derivatives
CA2182932A1 (en) * 1995-08-10 1997-02-11 Koju Watanabe Chromone derivative, process for preparing same and pharmaceutical composition
DE19850131A1 (en) * 1998-10-30 2000-05-04 Merck Patent Gmbh Chromenon and chromanone derivatives
AU3704400A (en) * 1999-03-04 2000-09-21 E.I. Du Pont De Nemours And Company Fused bicyclic oxazinone and thiazinone fungicides
CA2398163C (en) 2000-01-24 2011-02-22 Kinacia Pty Ltd. Therapeutic morpholino-substituted compounds
GB0119865D0 (en) 2001-08-14 2001-10-10 Cancer Res Campaign Tech DNA-PK inhibitors
GB0119863D0 (en) 2001-08-14 2001-10-10 Cancer Res Campaign Tech DNA-PK inhibitors
US7049313B2 (en) 2002-02-25 2006-05-23 Kudos Pharmaceuticals Ltd. ATM inhibitors
PL211300B1 (en) 2002-04-17 2012-05-31 Cytokinetics Inc Compounds, compositions, and methods
EP1539727B1 (en) 2002-07-17 2009-02-18 Cytokinetics, Inc. Compounds, compositions, and methods for treating cellular proliferative diseases
JP4646626B2 (en) * 2002-08-16 2011-03-09 アストラゼネカ アクチボラグ Inhibition of phosphoinositide 3-kinase β
CN100430389C (en) * 2002-08-16 2008-11-05 阿斯利康(瑞典)有限公司 Inhibition of phsphoinostide 3-dinase beta
CN100518740C (en) * 2003-06-06 2009-07-29 阿里克斯股份公司 Use of heterocyclic compounds as SCCE inhibitors
DK1631295T3 (en) * 2003-06-06 2010-06-21 Arexis Ab Use of Condensed Heterocyclic Compounds as SCCE Inhibitors in the Treatment of Skin Diseases
DE602004026071D1 (en) 2003-08-13 2010-04-29 Kudos Pharm Ltd AMINOPYRONE AND ITS USE AS ATM INHIBITORS
US8044057B2 (en) 2003-12-09 2011-10-25 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Methods for suppressing an immune response or treating a proliferative disorder
BRPI0515498A (en) 2004-09-20 2008-07-29 Kudos Pharm Ltd dna-pk inhibitors
TW200638938A (en) 2005-02-09 2006-11-16 Kudos Pharm Ltd ATM inhibitors
AR054438A1 (en) 2005-04-15 2007-06-27 Kudos Pharm Ltd DNA INHIBITORS -PK
EP2208728A4 (en) * 2007-09-19 2011-12-21 Inst Med Molecular Design Inc Heterocyclic derivative having inhibitory activity on type-i 11 -hydroxysteroid dehydrogenase
CA2738809C (en) 2008-09-29 2015-11-24 Sirtris Pharmaceuticals, Inc. Quinazolinone, quinolone and related analogs as sirtuin modulators
US8399460B2 (en) 2009-10-27 2013-03-19 Astrazeneca Ab Chromenone derivatives
US8530470B2 (en) 2011-04-13 2013-09-10 Astrazeneca Ab Chromenone derivatives
RU2468018C1 (en) * 2011-10-06 2012-11-27 Федеральное государственное бюджетное образовательное учреждение высшего профессионального образования "Российский университет дружбы народов" (РУДН) Method of producing 4-oxo-4h-chromene derivatives containing vinyl and enamine groups
EP2808322B1 (en) * 2012-01-26 2017-08-23 Daiichi Sankyo Company, Limited Chromone derivative having osteogenesis promoting effect
WO2014030688A1 (en) * 2012-08-24 2014-02-27 第一三共株式会社 Chromone derivative having linear side chain
AU2014224445C1 (en) 2013-03-04 2017-07-27 Astrazeneca Ab Combination treatment
CN108929329B (en) * 2017-05-24 2020-12-11 中国医学科学院药物研究所 2-azacyclo-5-trifluoromethyl-8-nitrobenz (thio) pyran-4-ones
CN108947952B (en) * 2017-05-24 2021-09-21 中国医学科学院药物研究所 2-substituted amino-5-trifluoromethyl-8-nitrobenz (thio) pyran-4-ketone compound and preparation method and application thereof
AR121719A1 (en) 2020-04-03 2022-06-29 Petra Pharma Corp ALLESTERIC INHIBITORS OF CHROMENONE OF PHOSPHOINOSITIDE 3-KINASE (PI3K) FOR THE TREATMENT OF DISEASES
MX2023013080A (en) 2021-05-03 2023-11-16 Petra Pharma Corp Allosteric chromenone inhibitors of phosphoinositide 3-kinase (pi3k) for the treatment of disease.
JP2024520417A (en) 2021-05-27 2024-05-24 ペトラ・ファーマ・コーポレイション Allosteric chromenone inhibitors of phosphoinositide 3-kinase (PI3K) for the treatment of cancer - Patent Application 20070223333
TW202329930A (en) 2021-09-30 2023-08-01 美商佩特拉製藥公司 Allosteric chromenone inhibitors of phosphoinositide 3-kinase (pi3k) for the treatment of disease

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2205913A1 (en) * 1972-02-08 1973-08-16 Thiemann Chem Pharm Fab 2-AMINO-3-HYDROXY-CHROMONE DERIVATIVES, THE PROCESS FOR THEIR MANUFACTURING AND MEDICINAL PRODUCTS CONTAINING THESE COMPOUNDS
DE2555290A1 (en) * 1975-12-09 1977-06-16 Boehringer Mannheim Gmbh NEW BENZOPYRONE DERIVATIVES AND METHOD FOR THEIR PRODUCTION
US4412071A (en) * 1982-05-17 1983-10-25 The Upjohn Company Antiatherosclerotic compositions
ZA873745B (en) * 1986-06-04 1988-10-26 Daiichi Seiyaku Co Benzopyran derivatives
MA21528A1 (en) * 1988-04-06 1989-12-31 Lipha SUBSTITUTE COMPONENTS OF FLAVONOIDE, THEIR SALTS, THEIR MANUFACTURES AND PRODUCTS CONTAINING THESE MATERIALS.

Also Published As

Publication number Publication date
AU4807190A (en) 1990-07-10
HU211339A9 (en) 1995-11-28
HUT58310A (en) 1992-02-28
RU2118321C1 (en) 1998-08-27
DK118791A (en) 1991-06-19
JPH04502322A (en) 1992-04-23
FI912995A0 (en) 1991-06-19
WO1990006921A1 (en) 1990-06-28
EP0459983A1 (en) 1991-12-11
AU634994B2 (en) 1993-03-11
DK118791D0 (en) 1991-06-19

Similar Documents

Publication Publication Date Title
HU900394D0 (en) Process for producing a new compound of medical effect and pharmaceutical preparatives containing it
HU901084D0 (en) Process for producing a new compound having medical effect and pharmaceutical preparatives containing it
HU905917D0 (en) Process for producing sulfinic and sulfonamidic derivatives of dioles and pharmaceutical preparatives containing these compounds
HU904169D0 (en) Process for producing new hetrazepines of paf-antagonistic effect and pharmaceutical preparations containing these compounds
HU904911D0 (en) Process for producing 1hrh analogues of reduced size and pharmaceutical preparatives containing them
HU900517D0 (en) Process for producing quinuclidine derivatives and pharmaceutical preparatives containing these compounds
GR890100314A (en) Process for the preparation of drug absorbates
HUT44787A (en) Process for production of derivatives of nitrofurane and medical preparatives containing these compounds
HU893408D0 (en) Process for the production of glycosamino-glucane salts and medical preparations containing them
EP0420930A4 (en) Method of synthesis and novel compounds for pharmaceutical uses
HU903196D0 (en) Process for producing benzocycloalkane derivatives and pharmaceutical preparatives containing these compounds
HUT48904A (en) Process for production of derivatives of 2-substituated adenosin and medical preparatives containing these substances
HU903907D0 (en) Process for producing pharmaceutical preparations against endoparasites containing 3-hydroxy-benzothiophene derivative and a part of active substances
HU903486D0 (en) Process for producing halogene-substituted diphenyl-sulfides and pharmaceutical preparatives containing these compounds
HU907178D0 (en) Process for producing pyridazine derivatives and pharmaceutical preparatives containing these compounds
HUT51247A (en) Process for production of aryl-zyanguananidins and medical compositions containing them
HU906302D0 (en) Process for producing 3'azido-purine-nucleosides and pharmaceutical preparatives containing these compounds
HU906498D0 (en) Process for producing new aryloxy-alcoyl-benzenes and pharmaceutical preparatives containing these compounds
HUT54703A (en) Process for producing epypodophyllotoxin-altroside derivatives and pharmaceutical preparatives containing these compounds
HUT50167A (en) Process for production of derivatives of tetrasole and medical compositions containing them
HU907176D0 (en) Process for producing 3-amino-pyrrhole derivatives and pharmaceutical preparatives containing these compounds
HU902460D0 (en) Process for producing new azetidine derivatives and pharmaceutical preparatives containing these compounds
HUT48579A (en) Process for production of derivatives of pirrolidine and medical preparatives containing these substances
HUT48278A (en) Process for production of rhenin-hindering dipeptides and medical preparatives containing them
HUT49131A (en) Process for producing new pyrazolo- and indazolo-pyridin-amine derivatives and pharmaceutical compositions containing them

Legal Events

Date Code Title Description
DFD9 Temporary prot. cancelled due to non-payment of fee